Skip to main content
14 August 2026
16 September 2025

Matica Bio Secures GMP Manufacturing Deal for Advanced Therapy

 Matica Biotechnology, Inc, a leading contract development and manufacturing organization (CDMO) specializing in viral vector manufacturing for cell and gene therapies, announced a strategic commercial manufacturing agreement with a clinical-stage biotech company based in the United States. This partnership marks a s…

16 September 2025

Labcorp Completes Acquisition of BioReference Health Assets

Labcorp , a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc., a multinational biopharmaceutical and diagnostics company, announced today the completion of Labcorp's acquisition of select assets of BioReference Health, a wholly owned subsidiary of OPKO Health. This acquisition i…

15 September 2025

Cytiva Joins Forces with WhiteLab Genomics to Advance AI in Cell Line Development

Cytiva, a Danaher company and a global leader in the life sciences industry, and WhiteLab Genomics, a techbio company specializing in artificial intelligence for genomic medicine research and development, announced a collaboration to accelerate the development of next-generation genomic medicines. As part of this col…

08 September 2025

SOPHiA GENETICS Teams Up with Jessa Ziekenhuis for Advanced NGS Workflows

SOPHiA GENETICS a cloud-native healthcare technology company and a global leader in data-driven medicine, has announced a significant new collaboration with Jessa Ziekenhuis in Hasselt, Belgium. The institutions will partner to bring cutting edge genomic testing and oncology research to cancer patients across Belgium.…

05 September 2025

Zydus, Synthon Join Forces for U.S. Market Entry of Ozanimod Capsules

 Zydus Lifesciences Ltd. a global innovation-driven healthcare company, announced that its wholly owned subsidiary, Zydus Lifesciences Global FZE, has entered into an exclusive licensing and supply agreement with Synthon BV of the Netherlands for Ozanimod Capsules (a generic version of ZEPOSIA®) for the U.S. market. S…

03 September 2025

LOTTE BIOLOGICS Partners with U.S. Biopharma Giant for Late-Stage Manufacturing

LOTTE BIOLOGICS announced that it has entered a late-stage to commercial contract manufacturing partnership with a U.S.-based global biopharmaceutical company. The partnership covers a late-stage Phase 3 program that is advancing into multiple new indications, and extends to commercial supply following potential regu…

29 August 2025

IQVIA Teams Up with Flagship to Advance Biopharma Innovation

IQVIA, a leading global provider of clinical research services, commercial insights and healthcare intelligence, and Flagship Pioneering, the bioplatform innovation company, announced a strategic collaboration to accelerate the development of breakthrough life sciences companies. The collaboration will help the Flagsh…

29 August 2025

OPTEL Acquires Vanguard Robotics to Tackle Pharma Workforce Challenges

OPTEL Group, a global leader in pharmaceutical traceability and supply chain solutions, proudly announces the acquisition of Vanguard Robotics, an expert in end-of-line collaborative robot (cobot) automation. This strategic move reinforces OPTEL's commitment to innovation and positions the company at the forefront of …

28 August 2025

NWBio Expands with Advent BioServices Acquisition to Drive Growth

Northwest Biotherapeutics, Inc. a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, announced that it has entered into an agreement to acquire Advent BioServices Ltd. from its owner, Toucan Holdings LLC. The transaction is expected to close as soon as certain legal condition…

26 August 2025

Boehringer & LEO Pharma Join Forces to Drive Innovation with SPEVIGO

Boehringer Ingelheim and LEO Pharma announced an exclusive global license and transfer agreement to commercialize and advance the development of SPEVIGO. Under the terms of the agreement, LEO Pharma will be responsible for commercialization and further development of SPEVIGO® leveraging its global commercial platform…

Page 28 of 36